started · updated
FDA panel recommends approval for Grail’s Galleri cancer blood test
An FDA advisory panel has recommended the approval of Grail Inc.’s Galleri test, a multi-cancer early detection blood test designed to screen adults aged 50 and older. In a recent meeting, the Molecular and Clinical Genetics Devices Panel voted 7-2, with one abstention, that the potential benefits of the test outweigh its risks. The panel also reached a unanimous 10-0 decision regarding the test’s safety.
However, experts remained divided on the test’s effectiveness, with a 6-4 vote indicating split opinions on whether there is reasonable assurance of its clinical efficacy. While the test identifies cancer-specific methylation patterns in cell-free DNA to signal the presence of tumors, some committee members expressed concerns that current data does not definitively prove it reduces cancer mortality or qualifies as a true “early detection” tool.
If the FDA grants final approval, the test could see widespread adoption and coverage by Medicare and private insurers. Currently, the test is available in the U.S. for out-of-pocket purchase. The FDA is not legally bound by the panel’s recommendation and is expected to make a final decision in the coming months.
Entities
FDA · Food and Drug Administration · Galleri · Grail Inc. · Molecular and Clinical Genetics Devices Panel · U.S. Food and Drug Administration · United States
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 11 SOURCES] The panel voted 10-0 that there is reasonable assurance the Galleri test is safe. www.cnbce.com · mugglehead.com · borncity.com · www.finanzen.at · www.finanzen.ch · +6 more
- [● 11 SOURCES] The panel voted 6-4 that there is reasonable assurance of the test's effectiveness. www.cnbce.com · mugglehead.com · borncity.com · www.finanzen.at · www.finanzen.ch · +6 more
- [● 15 SOURCES] The FDA advisory panel voted 7-2, with one abstention, that the benefits of the Galleri test outweigh its risks. www.cnbce.com · mugglehead.com · borncity.com · www.finanzen.at · www.finanzen.ch · +10 more
- [● 10 SOURCES] The Galleri test is designed to screen adults aged 50 and older for multiple types of cancer using cell-free DNA methylation patterns. www.cnbce.com · mugglehead.com · www.finanzen.at · www.finanzen.ch · www.ntd.com · +5 more
- [● 9 SOURCES] The FDA is not legally bound by the advisory panel's recommendation and will make a final decision in the coming months. www.cnbce.com · mugglehead.com · www.ntd.com · www.wdio.com · www.whec.com · +4 more
- [● 2 SOURCES] Clinical studies indicate the test can detect more cancers than standard screening alone, often at earlier, more treatable stages. www.finanzen.at · www.finanzen.ch